Palomino Laboratories (PALX) Other Accumulated Expenses (2022 - 2025)
Palomino Laboratories (PALX) posted Other Accumulated Expenses of $2740.0 for Q3 2025, down 57.85% sequentially from $6500.0 in Q2 2025, and down 93.88% YoY from $44750.0 in Q3 2024.
Palomino Laboratories (PALX) Other Accumulated Expenses (2022 - 2025) Analysis & Trends
Palomino Laboratories has reported Other Accumulated Expenses for 4 years, with the latest figure at $2740.0 in Q3 2025.
- Quarterly Other Accumulated Expenses fell 93.88% year-over-year to $2740.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2740.0 (down 93.88% YoY) and the FY2024 annual result came in at $3140.0, down 90.19% from the prior year.
- Other Accumulated Expenses retreated to $2740.0 in Q3 2025 per PALX's latest filing, from $6500.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $44750.0 in Q3 2024 and troughed at $2250.0 in Q1 2025.
- A 4-year average of $20347.8 and a median of $15000.0 in 2022 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2023 and 2025: Other Accumulated Expenses soared 113.33% in 2023, then plunged 93.88% in 2025.
- Over 4 years, Other Accumulated Expenses stood at $15000.0 in 2022, then jumped by 113.33% to $32000.0 in 2023, then plunged by 90.19% to $3140.0 in 2024, then declined by 12.74% to $2740.0 in 2025.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $2740.0, $6500.0, and $2250.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2,740.00 |
| Jun 30, 2025 | 6,500.00 |
| Mar 31, 2025 | 2,250.00 |
| Dec 31, 2024 | 3,140.00 |
| Sep 30, 2024 | 44,750.00 |
| Jun 30, 2024 | 40,500.00 |
| Mar 31, 2024 | 36,250.00 |
| Dec 31, 2023 | 32,000.00 |
| Dec 31, 2022 | 15,000.00 |